Global Structural Heart Imaging Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Imaging Modality;
Echocardiogram and Angiogram - CT and MRI.By Procedure;
TAVR, SAVR, and TMVRBy End Use;
Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Imaging Centers.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Structural Heart Imaging Market (USD Million), 2021 - 2031
In the year 2024, the Global Structural Heart Imaging Market was valued at USD 22,001.78 million. The size of this market is expected to increase to USD 38,695.70 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.4%.
The global structural heart imaging market is experiencing rapid growth, driven by advancements in medical imaging technologies and an increasing demand for non-invasive diagnostic procedures. Structural heart diseases (SHD), which affect the valves, walls, and chambers of the heart, are among the leading causes of cardiovascular morbidity and mortality worldwide. As the prevalence of heart diseases rises, the need for accurate and early diagnosis of SHD becomes more critical, fostering the demand for imaging systems that can provide detailed visualization of the heart's anatomy and function. These imaging technologies enable healthcare professionals to make informed decisions for the management and treatment of patients with heart conditions.
The market for structural heart imaging encompasses a wide range of imaging modalities, including echocardiography, computed tomography (CT), magnetic resonance imaging (MRI), and fluoroscopy, among others. Each of these technologies offers distinct advantages for visualizing the complex structures of the heart, allowing for improved detection, assessment, and monitoring of heart disease. With the ongoing integration of artificial intelligence (AI) and machine learning into imaging systems, the precision and efficiency of diagnostic imaging have significantly improved, enhancing the overall healthcare experience for patients and clinicians alike. Additionally, AI-driven solutions are assisting in automating the analysis of imaging data, making it faster and more accurate.
The growth of the global structural heart imaging market is also influenced by the rising awareness about heart health and the increasing number of minimally invasive procedures being performed to treat structural heart diseases. The development of advanced imaging technologies such as 3D echocardiography and transesophageal echocardiography (TEE) has improved the diagnostic capabilities and treatment outcomes for patients with structural heart issues. Furthermore, the growing adoption of these technologies by hospitals and imaging centers, coupled with favorable government initiatives and investments in healthcare infrastructure, is expected to propel market expansion in the coming years. As the demand for more accurate and efficient cardiovascular diagnostic tools continues to rise, the structural heart imaging market is poised for significant growth.
Global Structural Heart Imaging Market Recent Developments
-
In October 2023, GE Healthcare launched its enhanced venue family point-of-care ultrasound system with features like AI-driven caption guidance. That allows the surgeon to perform cardiac examination with real-time guidance.
-
In August 2023, Canon Medical announced the launch of their new angiography system Alphe Cnix/Evolve Edition for commercial sale in Asian, African, and European countries
Segment Analysis
The global structural heart imaging market is segmented based on technology, application, and geography. In terms of technology, the market is dominated by imaging modalities such as echocardiography, computed tomography (CT), magnetic resonance imaging (MRI), and fluoroscopy. Echocardiography holds a significant share due to its non-invasive nature, ease of use, and widespread adoption in clinical settings. It is primarily used for the assessment of heart valves, chambers, and overall cardiac function. Meanwhile, CT and MRI are gaining traction for their ability to provide high-resolution, detailed images, particularly in complex cases, including valve diseases and congenital heart defects. Fluoroscopy remains relevant in guiding interventional procedures, although its use is somewhat limited by radiation exposure.
By application, the market is primarily segmented into diagnostics and treatment planning, with diagnostics holding the largest share. Structural heart diseases, including aortic stenosis, mitral regurgitation, and atrial septal defects, require accurate imaging for early detection and assessment. Diagnostics help in identifying these conditions at an early stage, which significantly improves patient outcomes through timely interventions. The treatment planning segment is expected to grow as minimally invasive procedures for heart valve replacement and repair, like transcatheter aortic valve replacement (TAVR), gain popularity. These procedures rely heavily on advanced imaging for preoperative planning, real-time guidance, and post-operative monitoring.
Geographically, North America leads the global market due to advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of innovative imaging technologies. The region also benefits from the presence of major market players and favorable reimbursement policies. Europe follows closely behind, with the rising adoption of advanced imaging techniques and a growing emphasis on minimally invasive procedures. The Asia-Pacific region is expected to experience the highest growth due to the expanding healthcare infrastructure, increasing awareness of heart diseases, and improving access to advanced medical technologies. The market in this region is further driven by rising cardiovascular disease prevalence and government initiatives to enhance healthcare services.
Global Structural Heart Imaging Segment Analysis
In this report, the Global Structural Heart Imaging Market has been segmented by Imaging Modality, Procedure, End Use, and Geography.
Global Structural Heart Imaging Market, Segmentation by Imaging Modality
The Global Structural Heart Imaging Market has been segmented by Imaging Modality into Echocardiogram and Angiogram.
The echocardiogram segment holds a dominant position due to its non-invasive nature, affordability, and ease of use. It is commonly employed in routine clinical settings to assess the heart's structure, including the chambers, valves, and overall cardiac function. Echocardiograms, particularly transthoracic and transesophageal echocardiography, offer real-time images and play a vital role in diagnosing a wide range of structural heart diseases such as valvular conditions and congenital heart defects. Despite its limitations in certain complex cases, its cost-effectiveness and non-invasive approach continue to make it the preferred modality for initial assessments.
The angiogram-CT segment is growing rapidly, primarily driven by the increasing demand for high-resolution imaging and accurate visualization of coronary and cardiac anatomy. CT angiography offers detailed images of blood vessels, allowing for the precise assessment of conditions like coronary artery disease, aortic aneurysms, and valvular diseases. With advancements in multi-detector CT scanners, the speed and resolution of these procedures have significantly improved, making them suitable for comprehensive cardiac evaluations. CT angiography's ability to provide 3D reconstructions enhances treatment planning for structural heart diseases, particularly in guiding interventional procedures such as stent placement or valve replacement. However, concerns regarding radiation exposure limit its use in some cases.
MRI has emerged as a powerful tool in structural heart imaging, especially for assessing complex cardiac conditions. Unlike CT, MRI does not involve radiation, making it an attractive option for certain patient populations, such as those requiring repeated imaging. Cardiac MRI provides high-resolution, detailed images of both the heart’s structure and function, making it particularly useful for evaluating myocardial diseases, heart failure, and congenital heart defects. The ability of MRI to assess both soft tissue and vascular structures makes it a versatile imaging modality for diagnosing and monitoring various heart conditions. Although MRI equipment is more expensive and requires longer scan times, its advantages in non-invasive imaging and comprehensive cardiac evaluation are driving its increasing adoption in clinical practice.
Global Structural Heart Imaging Market, Segmentation by Procedure
The Global Structural Heart Imaging Market has been segmented by Procedure into TAVR, SAVR, TMVR
The global structural heart imaging market is also segmented by procedure, with key procedures including Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), and Transcatheter Mitral Valve Repair (TMVR). TAVR has gained significant traction due to its minimally invasive nature, offering an alternative to open-heart surgery for patients with aortic valve stenosis. TAVR procedures rely heavily on advanced imaging modalities, such as echocardiography, CT, and fluoroscopy, for precise valve positioning and deployment. The increasing number of elderly patients and the growing preference for less invasive treatment options have driven the widespread adoption of TAVR, making it one of the leading segments in the structural heart imaging market.
SAVR remains a key procedure, particularly for younger and low-risk patients who are better suited for traditional open-heart surgery. Although less commonly used than TAVR due to its more invasive nature, SAVR continues to be important in cases where TAVR is not viable. Surgical aortic valve replacement procedures require detailed preoperative imaging to assess the anatomy of the heart, blood vessels, and the aortic valve, as well as intraoperative imaging for guidance during valve placement. Advanced imaging technologies, such as CT and MRI, help ensure the correct positioning of the valve during surgery. While the adoption of SAVR may be slowing with the rise of TAVR, it still remains a vital part of structural heart interventions, particularly in younger patients or those with specific complications.
TMVR is a relatively newer and emerging procedure aimed at repairing or replacing the mitral valve through a catheter-based approach, offering a less invasive alternative to traditional mitral valve surgery. The growing prevalence of mitral regurgitation, particularly in aging populations, has fueled the demand for TMVR. Like TAVR, TMVR requires high-quality imaging for accurate preoperative planning, device deployment, and post-procedure evaluation. Imaging modalities such as echocardiography, CT, and fluoroscopy play a critical role in guiding the procedure and ensuring optimal outcomes. As TMVR continues to evolve and gain FDA approvals for a broader range of patients, it is expected to drive significant growth in the structural heart imaging market, particularly in the context of non-invasive valve repair and replacement procedures.
Global Structural Heart Imaging Market, Segmentation by End Use
The Global Structural Heart Imaging Market has been segmented by End Use into Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Imaging Centers.
The end-use segmentation in the global structural heart imaging market highlights the diverse applications and user environments where these technologies are utilized. Hospitals and clinics dominate the market as primary care providers for structural heart conditions. These facilities often serve as the first point of contact for patients and are equipped with advanced imaging technologies like echocardiography, CT, and MRI. They provide critical diagnostics and treatment planning for conditions such as valvular heart disease, congenital heart defects, and cardiomyopathies. The presence of skilled professionals and infrastructure ensures accurate and comprehensive imaging, fostering trust and reliability in this segment.
Ambulatory surgical centers are gaining prominence in the structural heart imaging market due to their cost-effective and specialized approach. These centers focus on outpatient procedures and diagnostics, making them a preferred choice for patients seeking convenience and quicker turnaround times. Equipped with portable imaging devices and minimally invasive technologies, ambulatory centers cater to less complex cases of structural heart abnormalities. Their streamlined operations and lower procedural costs make them an attractive option for both patients and healthcare providers, driving growth in this segment.
Diagnostic imaging centers play a vital role in the market by providing dedicated imaging services that support early detection and treatment planning. These centers often collaborate with hospitals and clinics to deliver specialized imaging solutions, such as 3D echocardiography and cardiac MRI. With a focus on innovation and precision, diagnostic imaging centers enhance the overall diagnostic accuracy for structural heart conditions. Their integration with advanced technologies and expert radiologists ensures high-quality imaging outputs, making them indispensable in comprehensive cardiac care.
Global Structural Heart Imaging Market, Segmentation by Geography
In this report, the Global Structural Heart Imaging Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The zion global services are spread across north america, europe, asia pacific, uae, dubai, saudi arabia, singapore, and others.
Global Structural Heart Imaging Market Share (%), by Geographical Region, 2024
The global structural heart imaging market is segmented by geography, with key regions including North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. North America leads the market, driven by a highly developed healthcare infrastructure, a large patient population with cardiovascular diseases, and significant investment in advanced imaging technologies. The United States, in particular, has been at the forefront of adopting state-of-the-art imaging modalities, such as 3D echocardiography, MRI, and CT, which are essential for the precise diagnosis and treatment of structural heart diseases. Moreover, the region benefits from favorable reimbursement policies and the presence of major market players, which further accelerates the growth of the structural heart imaging market.
Europe holds a prominent position in the structural heart imaging market, bolstered by an aging population, increasing prevalence of cardiovascular diseases, and a strong healthcare system. Countries such as Germany, France, and the UK are investing heavily in advanced imaging solutions, which are crucial for guiding minimally invasive procedures like TAVR and TMVR. The European market is characterized by a growing emphasis on early detection and non-invasive diagnostic techniques, which has driven the demand for advanced imaging modalities. Additionally, Europe's focus on reducing healthcare costs has resulted in greater adoption of cost-effective and efficient imaging systems, further promoting the growth of the market in this region.
The Asia Pacific region is anticipated to witness the highest growth rate in the structural heart imaging market due to factors such as the increasing prevalence of heart diseases, improving healthcare infrastructure, and greater access to advanced medical technologies. Countries like China, India, and Japan are investing in modernizing their healthcare systems, which is expected to drive the adoption of structural heart imaging solutions. Additionally, rising awareness about heart health, government initiatives to address cardiovascular diseases, and increasing healthcare expenditure in developing countries are fueling market growth in the Asia Pacific. Meanwhile, the Middle East and Africa and Latin America are also witnessing steady growth, driven by improving healthcare facilities, rising cardiovascular disease incidence, and increased investment in advanced imaging technology. However, these regions face challenges related to the affordability and accessibility of advanced imaging systems.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Structural Heart Imaging Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing prevalence of cardiovascular diseases
- Advancements in imaging technologies (e.g., 3D imaging, AI integration)
- Rising demand for non-invasive diagnostic tools
-
Growing adoption of minimally invasive procedures-The growing adoption of minimally invasive procedures is a significant driver of the structural heart imaging market, as these techniques offer numerous advantages over traditional open-heart surgeries. Minimally invasive procedures, such as Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral Valve Repair (TMVR), are increasingly preferred due to their ability to reduce patient recovery time, minimize surgical risks, and shorten hospital stays. These benefits are especially crucial for elderly or high-risk patients who may not be suitable candidates for conventional surgery. As healthcare providers focus on improving patient outcomes while reducing healthcare costs, the demand for minimally invasive approaches continues to rise, driving the need for advanced imaging technologies that ensure precision during these complex procedures.
In addition to the clinical benefits, minimally invasive procedures also allow for more cost-effective treatments compared to traditional surgeries. The reduction in recovery times and hospital admissions leads to lower overall healthcare costs, which makes these procedures appealing to both healthcare providers and patients. The increased availability of advanced imaging modalities, such as 3D echocardiography, CT, and MRI, has further enhanced the effectiveness of these procedures, providing healthcare professionals with real-time, high-resolution images that help guide device placement, monitor the heart’s response to treatment, and ensure optimal outcomes. As a result, minimally invasive heart procedures are being adopted at a faster rate, fueling the growth of the structural heart imaging market.
Restraints
- High cost of advanced imaging systems
- Limited reimbursement policies in some regions
- Lack of skilled professionals for interpreting complex imaging
-
Technical limitations of certain imaging modalities-Despite the significant advancements in structural heart imaging, there are still technical limitations associated with certain imaging modalities that can hinder their effectiveness in diagnosing and treating structural heart diseases. For instance, while echocardiography is widely used and accessible, it has limitations in terms of image resolution and the ability to visualize complex anatomical structures, especially in obese patients or those with poor acoustic windows. These limitations can lead to suboptimal diagnostic accuracy and may require additional imaging tests, which could increase the overall cost and complexity of the diagnosis.
Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), while providing high-resolution and detailed images, also face their own set of challenges. CT imaging, though effective for visualizing coronary arteries and other vascular structures, exposes patients to ionizing radiation, which can limit its use, particularly in young patients or those requiring repeated imaging. Additionally, the availability of multi-detector CT scanners, which offer better image quality, is often limited in certain regions due to high costs, making it less accessible in developing healthcare settings. MRI, although non-invasive and radiation-free, has limitations such as long scan times, high equipment costs, and the requirement for patients to remain still for extended periods, which can be difficult for those with severe cardiac conditions or claustrophobia.
Opportunities
- Emerging AI and machine learning innovations
- Growing healthcare infrastructure in developing regions
- Expansion of telemedicine and remote diagnostics
-
Development of portable and cost-effective imaging device-The development of portable and cost-effective imaging devices is a transformative trend in the structural heart imaging market, making advanced diagnostic tools more accessible to a broader range of healthcare providers, particularly in resource-limited settings. Traditional imaging systems, such as high-end CT and MRI scanners, are often expensive, require significant space, and are associated with high operational costs. In contrast, portable imaging devices, including handheld ultrasound machines and compact echocardiography systems, are significantly more affordable and can be easily used in a variety of clinical environments, including outpatient clinics, emergency rooms, and rural or remote areas. This portability allows healthcare providers to offer timely diagnosis and treatment planning without the need for patients to travel to specialized centers, improving patient outcomes, particularly in underserved regions.
In addition to their cost-effectiveness, portable imaging devices are advancing in terms of technological sophistication. For instance, handheld ultrasound devices have evolved to offer high-resolution imaging that can rival larger, stationary systems. These devices are now capable of performing detailed assessments of heart valve function, blood flow, and chamber sizes, which are critical for diagnosing structural heart diseases. Furthermore, the integration of artificial intelligence (AI) and machine learning algorithms into these portable devices is enhancing their diagnostic accuracy, enabling even non-specialist healthcare providers to interpret images quickly and efficiently. This reduces the dependency on highly specialized personnel and speeds up the clinical decision-making process, contributing to better patient care.
Competitive Landscape Analysis
Key players in Global Structural Heart Imaging Market include:
- GE Healthcare
- Siemens Healthineers AG
- Koninklijke Philips N.V
- Canon Medical System, USA
- Boston Scientific corporation
- Medtronic
- Edwards Lifesciences Corporation
- Bracco
- FUJIFILM Holdings Corporations
- Hitachi, Ltd
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Imaging Modality
- Market Snapshot, By Procedure
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Global Structural Heart Imaging Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing prevalence of cardiovascular diseases
- Advancements in imaging technologies (e.g., 3D imaging, AI integration)
- Rising demand for non-invasive diagnostic tools
- Growing adoption of minimally invasive procedures
- Restraints
- High cost of advanced imaging systems
- Limited reimbursement policies in some regions
- Lack of skilled professionals for interpreting complex imaging
- Technical limitations of certain imaging modalities
- Opportunities
- Emerging AI and machine learning innovations
- Growing healthcare infrastructure in developing regions
- Expansion of telemedicine and remote diagnostics
- Development of portable and cost-effective imaging device
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Structural Heart Imaging Market, By Imaging Modality, 2021 - 2031 (USD Million)
- Echocardiogram
- Angiogram
- CT
- MRI
- Global Structural Heart Imaging Market, By Procedure, 2021 - 2031 (USD Million)
- TAVR
- SAVR
- TMVR
- Global Structural Heart Imaging Market, By End Use , 2021- 2031 (USD Million)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Diagnostic Imaging Centers
- Global Structural Heart Imaging Market, By Geography, 2021- 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Structural Heart Imaging Market, By Imaging Modality, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- GE Healthcare
- Siemens Healthineers AG
- Koninklijke Philips N.V
- Canon Medical System, USA
- Boston Scientific corporation
- Medtronic
- Edwards Lifesciences Corporation
- Bracco
- FUJIFILM Holdings Corporations
- Hitachi, Ltd
- Company Profiles
- Analyst Views
- Future Outlook of the Market